Cellular and molecular mechanisms of probiotics effects on colorectal cancer

Journal of Functional Foods

Volumn 18, Issue , 2015, Pages 463-472

  Faghfoori, Zeinab ^a,b   Pourghassem Gargari, Bahram ^c,d   Saber Gharamaleki, Amir ^c,d   Bagherpour, Hassan ^e   Yari Khosroushahi, Ahmad ^e,f  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Colorectal cancer; Diet; Microbiota; Probiotic bacteria

Indexed keywords

EID: 84942515920     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2015.08.013     Document Type: Review

References (99)

1. Abid Z., Cross A.J., Sinha R. Meat, dairy, and cancer. The American Journal of Clinical Nutrition 2014, 100(Suppl. 1):386S-393S.
2. Anderson R.C., Cookson A.L., McNabb W.C., Park Z., McCann M.J., Kelly W.J., Roy N.C. Lactobacillus plantarum MB452 enhances the function of the intestinal barrier by increasing the expression levels of genes involved in tight junction formation. BMC Microbiology 2010, 10:316.
3. Appleyard C.B., Cruz M.L., Isidro A.A., Arthur J.C., Jobin C., De Simone C. Pretreatment with the probiotic VSL#3 delays transition from inflammation to dysplasia in a rat model of colitis-associated cancer. American Journal of Physiology. Gastrointestinal and Liver Physiology 2011, 301(6):G1004-G1013.
4. Aranganathan S., Selvam J.P., Nalini N. Effect of hesperetin, a citrus flavonoid, on bacterial enzymes and carcinogen-induced aberrant crypt foci in colon cancer rats: A dose-dependent study. The Journal of Pharmacy and Pharmacology 2008, 60(10):1385-1392.
5. Arthur J.C., Gharaibeh R.Z., Uronis J.M., Perez-Chanona E., Sha W., Tomkovich S., Jobin C. VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer. Science Reports 2013, 3:2868.
6. Ashraf R., Shah N.P. Immune system stimulation by probiotic microorganisms. Critical Reviews in Food Science and Nutrition 2014, 54(7):938-956.
7. Barrasa J.I., Olmo N., Lizarbe M.A., Turnay J. Bile acids in the colon, from healthy to cytotoxic molecules. Toxicology in Vitro: An International Journal Published in Association With BIBRA 2013, 27(2):964-977.
8. Bassaganya-Riera J., Viladomiu M., Pedragosa M., De Simone C., Hontecillas R. Immunoregulatory mechanisms underlying prevention of colitis-associated colorectal cancer by probiotic bacteria. PLoS ONE 2012, 7(4):e34676.
9. Beppu F., Hosokawa M., Tanaka L., Kohno H., Tanaka T., Miyashita K. Potent inhibitory effect of trans9, trans11 isomer of conjugated linoleic acid on the growth of human colon cancer cells. The Journal of Nutritional Biochemistry 2006, 17(12):830-836.
10. Bernstein C., Holubec H., Bhattacharyya A.K., Nguyen H., Payne C.M., Zaitlin B., Bernstein H. Carcinogenicity of deoxycholate, a secondary bile acid. Archives of Toxicology 2011, 85(8):863-871.
11. Burns A.J., Rowland I.R. Antigenotoxicity of probiotics and prebiotics on faecal water-induced DNA damage in human colon adenocarcinoma cells. Mutation Research 2004, 551(1-2):233-243.
12. Canani R.B., Costanzo M.D., Leone L., Pedata M., Meli R., Calignano A. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World Journal of Gastroenterology 2011, 17(12):1519-1528.
13. Chen C.C., Lin W.C., Kong M.S., Shi H.N., Walker W.A., Lin C.Y., Lin T.Y. Oral inoculation of probiotics Lactobacillus acidophilus NCFM suppresses tumour growth both in segmental orthotopic colon cancer and extra-intestinal tissue. The British Journal of Nutrition 2012, 107(11):1623-1634.
14. Chen W., Liu F., Ling Z., Tong X., Xiang C. Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PLoS ONE 2012, 7(6):e39743.
15. Cho H.J., Kim E.J., Lim S.S., Kim M.K., Sung M.K., Kim J.S., Park J.H. Trans-10,cis-12, not cis-9,trans-11, conjugated linoleic acid inhibits G1-S progression in HT-29 human colon cancer cells. The Journal of Nutrition 2006, 136(4):893-898.
16. Cho H.J., Kim W.K., Jung J.I., Kim E.J., Lim S.S., Kwon D.Y., Park J.H. Trans-10,cis-12, not cis-9,trans-11, conjugated linoleic acid decreases ErbB3 expression in HT-29 human colon cancer cells. World Journal of Gastroenterology 2005, 11(33):5142-5150.
17. Cho H.J., Kim W.K., Kim E.J., Jung K.C., Park S., Lee H.S., Park J.H. Conjugated linoleic acid inhibits cell proliferation and ErbB3 signaling in HT-29 human colon cell line. American Journal of Physiology. Gastrointestinal and Liver Physiology 2003, 284(6):G996-G1005.
18. Chow J., Tang H., Mazmanian S.K. Pathobionts of the gastrointestinal microbiota and inflammatory disease. Current Opinion in Immunology 2011, 23(4):473-480.
19. Collado M.C., Jalonen L., Meriluoto J., Salminen S. Protection mechanism of probiotic combination against human pathogens: In vitro adhesion to human intestinal mucus. Asia Pacific Journal of Clinical Nutrition 2006, 15(4):570-575.
20. den Besten G., van Eunen K., Groen A.K., Venema K., Reijngoud D.J., Bakker B.M. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. Journal of Lipid Research 2013, 54(9):2325-2340.
21. Dai C., Zhao D.H., Jiang M. VSL#3 probiotics regulate the intestinal epithelial barrier in vivo and in vitro via the p38 and ERK signaling pathways. International Journal of Molecular Medicine 2012, 29(2):202-208.
22. Daroqui M.C., Augenlicht L.H. Transcriptional attenuation in colon carcinoma cells in response to butyrate. Cancer Prev Res (Phila) 2010, 3(10):1292-1302.
23. De la Torre A., Debiton E., Durand D., Chardigny J.M., Berdeaux O., Loreau O., Gruffat D. Conjugated linoleic acid isomers and their conjugated derivatives inhibit growth of human cancer cell lines. Anticancer Research 2005, 25(6B):3943-3949.
24. Debruyne P.R., Bruyneel E.A., Li X., Zimber A., Gespach C., Mareel M.M. The role of bile acids in carcinogenesis. Mutation Research 2001, 480-481:359-369.
25. Degirolamo C., Modica S., Palasciano G., Moschetta A. Bile acids and colon cancer: Solving the puzzle with nuclear receptors. Trends in Molecular Medicine 2011, 17(10):564-572.
26. Delcenserie V., Martel D., Lamoureux M., Amiot J., Boutin Y., Roy D. Immunomodulatory effects of probiotics in the intestinal tract. Current Issues in Molecular Biology 2008, 10(1-2):37-54.
27. Desbonnet L., Garrett L., Clarke G., Kiely B., Cryan J.F., Dinan T.G. Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience 2010, 170(4):1179-1188.
28. Djaldetti M., Bessler H. Modulators affecting the immune dialogue between human immune and colon cancer cells. World Journal of Gastrointestinal Oncology 2014, 6(5):129-138.
29. Erdman S.E., Rao V.P., Poutahidis T., Rogers A.B., Taylor C.L., Jackson E.A., Fox J.G. Nitric oxide and TNF-alpha trigger colonic inflammation and carcinogenesis in Helicobacter hepaticus-infected, Rag2-deficient mice. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(4):1027-1032.
30. Ewaschuk J.B., Walker J.W., Diaz H., Madsen K.L. Bioproduction of conjugated linoleic acid by probiotic bacteria occurs in vitro and in vivo in mice. The Journal of Nutrition 2006, 136(6):1483-1487.
31. Forsythe P., Bienenstock J. Immunomodulation by commensal and probiotic bacteria. Immunological Investigations 2010, 39(4-5):429-448.
32. Fuchs S., Sontag G., Stidl R., Ehrlich V., Kundi M., Knasmuller S. Detoxification of patulin and ochratoxin A, two abundant mycotoxins, by lactic acid bacteria. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 2008, 46(4):1398-1407.
33. Galdeano C.M., de Moreno de LeBlanc A., Vinderola G., Bonet M.E., Perdigon G. Proposed model: Mechanisms of immunomodulation induced by probiotic bacteria. Clinical and Vaccine Immunology 2007, 14(5):485-492.
34. Ganapathy V., Thangaraju M., Prasad P.D., Martin P.M., Singh N. Transporters and receptors for short-chain fatty acids as the molecular link between colonic bacteria and the host. Current Opinion in Pharmacology 2013, 13(6):869-874.
35. Garrett W.S., Punit S., Gallini C.A., Michaud M., Zhang D., Sigrist K.S., Glimcher L.H. Colitis-associated colorectal cancer driven by T-bet deficiency in dendritic cells. Cancer Cell 2009, 16(3):208-219.
36. Gold J.S., Bayar S., Salem R.R. Association of Streptococcus bovis bacteremia with colonic neoplasia and extracolonic malignancy. Archives of Surgery (Chicago, Ill.: 1960) 2004, 139(7):760-765.
37. Hamer H.M., Jonkers D., Venema K., Vanhoutvin S., Troost F.J., Brummer R.J. Review article: The role of butyrate on colonic function. Alimentary Pharmacology and Therapeutics 2008, 27(2):104-119.
38. Hardy H., Harris J., Lyon E., Beal J., Foey A.D. Probiotics, prebiotics and immunomodulation of gut mucosal defences: Homeostasis and immunopathology. Nutrients 2013, 5(6):1869-1912.
39. Hemarajata P., Versalovic J. Effects of probiotics on gut microbiota: Mechanisms of intestinal immunomodulation and neuromodulation. Therapy Advanced Gastroenterology 2013, 6(1):39-51.
40. Hill C., Guarner F., Reid G., Gibson G.R., Merenstein D.J., Pot B., Sanders M.E. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews. Gastroenterology & Hepatology 2014, 11(8):506-514.
41. Huang G., Zhong X., Cao Y., Chen Y. Antiproliferative effects of conjugated linoleic acid on human colon adenocarcinoma cell line Caco-2. Asia Pacific Journal of Clinical Nutrition 2007, 16(Suppl. 1):432-436.
42. Jeon M.K., Klaus C., Kaemmerer E., Gassler N. Intestinal barrier: Molecular pathways and modifiers. World Journal of Gastrointestinal Pathophysiology 2013, 4(4):94-99.
43. Karczewski J., Troost F.J., Konings I., Dekker J., Kleerebezem M., Brummer R.J., Wells J.M. Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. American Journal of Physiology. Gastrointestinal and Liver Physiology 2010, 298(6):G851-G859.
44. Kassie F., Rabot S., Kundi M., Chabicovsky M., Qin H.M., Knasmuller S. Intestinal microflora plays a crucial role in the genotoxicity of the cooked food mutagen 2-amino-3-methylimidazo [4,5-f]quinoline. Carcinogenesis 2001, 22(10):1721-1725.
45. Kim E., Coelho D., Blachier F. Review of the association between meat consumption and risk of colorectal cancer. Nutrition Research (New York, N.Y.) 2013, 33(12):983-994.
46. Kim E.J., Kang I.J., Cho H.J., Kim W.K., Ha Y.L., Park J.H. Conjugated linoleic acid downregulates insulin-like growth factor-I receptor levels in HT-29 human colon cancer cells. The Journal of Nutrition 2003, 133(8):2675-2681.
47. Kodali V.P., Sen R. Antioxidant and free radical scavenging activities of an exopolysaccharide from a probiotic bacterium. Biotechnology Journal 2008, 3(2):245-251.
48. Konstantinov S.R., Kuipers E.J., Peppelenbosch M.P. Functional genomic analyses of the gut microbiota for CRC screening. Nature Reviews. Gastroenterology & Hepatology 2013, 10(12):741-745.
49. Kumar M., Kumar A., Nagpal R., Mohania D., Behare P., Verma V., Yadav H. Cancer-preventing attributes of probiotics: An update. International Journal of Food Sciences and Nutrition 2010, 61(5):473-496.
50. Lee do K., Jang S., Baek E.H., Kim M.J., Lee K.S., Shin H.S., Ha N.J. Lactic acid bacteria affect serum cholesterol levels, harmful fecal enzyme activity, and fecal water content. Lipids in Health and Disease 2009, 8:21.
51. Liu Z., Qin H., Yang Z., Xia Y., Liu W., Yang J., Zheng Q. Randomised clinical trial: The effects of perioperative probiotic treatment on barrier function and post-operative infectious complications in colorectal cancer surgery - A double-blind study. Alimentary Pharmacology and Therapeutics 2011, 33(1):50-63.
52. Lozupone C.A., Stombaugh J.I., Gordon J.I., Jansson J.K., Knight R. Diversity, stability and resilience of the human gut microbiota. Nature 2012, 489(7415):220-230.
53. Ma E.L., Choi Y.J., Choi J., Pothoulakis C., Rhee S.H., Im E. The anticancer effect of probiotic Bacillus polyfermenticus on human colon cancer cells is mediated through ErbB2 and ErbB3 inhibition. International Journal of Cancer 2010, 127(4):780-790.
54. Martinez-Augustin O., Sanchez de Medina F. Intestinal bile acid physiology and pathophysiology. World Journal of Gastroenterology 2008, 14(37):5630-5640.
55. Mennigen R., Nolte K., Rijcken E., Utech M., Loeffler B., Senninger N., Bruewer M. Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis. American Journal of Physiology. Gastrointestinal and Liver Physiology 2009, 296(5):G1140-G1149.
56. Miller A., Stanton C., Devery R. Cis 9, trans 11- and trans 10, cis 12-conjugated linoleic acid isomers induce apoptosis in cultured SW480 cells. Anticancer Research 2002, 22(6C):3879-3887.
57. Miyauchi E., O'Callaghan J., Butto L.F., Hurley G., Melgar S., Tanabe S., O'Toole P.W. Mechanism of protection of transepithelial barrier function by Lactobacillus salivarius: Strain dependence and attenuation by bacteriocin production. American Journal of Physiology. Gastrointestinal and Liver Physiology 2012, 303(9):G1029-G1041.
58. Nami Y., Abdullah N., Haghshenas B., Radiah D., Rosli R., Khosroushahi A.Y. Assessment of probiotic potential and anticancer activity of newly isolated vaginal bacterium Lactobacillus plantarum 5BL. Microbiology and Immunology 2014, 58(9):492-502.
59. Nanda Kumar N.S., Balamurugan R., Jayakanthan K., Pulimood A., Pugazhendhi S., Ramakrishna B.S. Probiotic administration alters the gut flora and attenuates colitis in mice administered dextran sodium sulfate. Journal of Gastroenterology and Hepatology 2008, 23(12):1834-1839.
60. Nowak A., Libudzisz Z. Ability of probiotic Lactobacillus casei DN 114001 to bind or/and metabolise heterocyclic aromatic amines in vitro. European Journal of Nutrition 2009, 48(7):419-427.
61. Ogawa J., Kishino S., Ando A., Sugimoto S., Mihara K., Shimizu S. Production of conjugated fatty acids by lactic acid bacteria. Journal of Bioscience and Bioengineering 2005, 100(4):355-364.
62. Ohigashi S., Sudo K., Kobayashi D., Takahashi O., Takahashi T., Asahara T., Onodera H. Changes of the intestinal microbiota, short chain fatty acids, and fecal pH in patients with colorectal cancer. Digestive Diseases and Sciences 2013, 58(6):1717-1726.
63. O'Mahony L., Feeney M., O'Halloran S., Murphy L., Kiely B., Fitzgibbon J., Collins J.K. Probiotic impact on microbial flora, inflammation and tumour development in IL-10 knockout mice. Alimentary Pharmacology and Therapeutics 2001, 15(8):1219-1225.
64. Orlando A., Refolo M.G., Messa C., Amati L., Lavermicocca P., Guerra V., Russo F. Antiproliferative and proapoptotic effects of viable or heat-killed Lactobacillus paracasei IMPC2.1 and Lactobacillus rhamnosus GG in HGC-27 gastric and DLD-1 colon cell lines. Nutrition and Cancer 2012, 64(7):1103-1111.
65. Palombo J.D., Ganguly A., Bistrian B.R., Menard M.P. The antiproliferative effects of biologically active isomers of conjugated linoleic acid on human colorectal and prostatic cancer cells. Cancer Letters 2002, 177(2):163-172.
66. Paolillo R., Romano Carratelli C., Sorrentino S., Mazzola N., Rizzo A. Immunomodulatory effects of Lactobacillus plantarum on human colon cancer cells. International Immunopharmacology 2009, 9(11):1265-1271.
67. Pericleous M., Mandair D., Caplin M.E. Diet and supplements and their impact on colorectal cancer. Journal of Gastrointestinal Oncology 2013, 4(4):409-423.
68. Perse M. Oxidative stress in the pathogenesis of colorectal cancer: Cause or consequence?. Biomedicine Research International 2013, 2013:725710.
69. Rafter J. The effects of probiotics on colon cancer development. Nutrition Research Reviews 2004, 17(2):277-284.
70. Ramakrishna B.S. Probiotic-induced changes in the intestinal epithelium: Implications in gastrointestinal disease. Tropical Gastroenterology 2009, 30(2):76-85.
71. Ridlon J.M., Kang D.J., Hylemon P.B. Bile salt biotransformations by human intestinal bacteria. Journal of Lipid Research 2006, 47(2):241-259.
72. Sachse C., Smith G., Wilkie M.J., Barrett J.H., Waxman R., Sullivan F., Wolf C.R. A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. Carcinogenesis 2002, 23(11):1839-1849.
73. Sakata T., Kojima T., Fujieda M., Takahashi M., Michibata T. Influences of probiotic bacteria on organic acid production by pig caecal bacteria in vitro. The Proceedings of the Nutrition Society 2003, 62(1):73-80.
74. Sanders M.E. Impact of probiotics on colonizing microbiota of the gut. Journal of Clinical Gastroenterology 2011, 45(Suppl.):S115-S119.
75. Saulnier D.M., Ringel Y., Heyman M.B., Foster J.A., Bercik P., Shulman R.J., Guarner F. The intestinal microbiome, probiotics and prebiotics in neurogastroenterology. Gut Microbes 2013, 4(1):17-27.
76. Savard P., Lamarche B., Paradis M.E., Thiboutot H., Laurin E., Roy D. Impact of Bifidobacterium animalis subsp. lactis BB-12 and, Lactobacillus acidophilus LA-5-containing yoghurt, on fecal bacterial counts of healthy adults. International Journal of Food Microbiology 2011, 149(1):50-57.
77. Sharma R., Kapila R., Dass G., Kapila S. Improvement in Th1/Th2 immune homeostasis, antioxidative status and resistance to pathogenic E. coli on consumption of probiotic Lactobacillus rhamnosus fermented milk in aging mice. Age (Dordr) 2014, 36(4):9686.
78. Shen L., Su L., Turner J.R. Mechanisms and functional implications of intestinal barrier defects. Digestive Diseases (Basel, Switzerland) 2009, 27(4):443-449.
79. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2012. CA: A Cancer Journal for Clinicians 2012, 62(1):10-29.
80. Smolinska K., Paluszkiewicz P. Risk of colorectal cancer in relation to frequency and total amount of red meat consumption. Systematic review and meta-analysis. Archives of Medical Science 2010, 6(4):605-610.
81. Sobhani I., Tap J., Roudot-Thoraval F., Roperch J.P., Letulle S., Langella P., Furet J.P. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS ONE 2011, 6(1):e16393.
82. Sokol H., Pigneur B., Watterlot L., Lakhdari O., Bermudez-Humaran L.G., Gratadoux J.J., Langella P. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proceedings of the National Academy of Sciences of the United States of America 2008, 105(43):16731-16736.
83. Soler A.P., Miller R.D., Laughlin K.V., Carp N.Z., Klurfeld D.M., Mullin J.M. Increased tight junctional permeability is associated with the development of colon cancer. Carcinogenesis 1999, 20(8):1425-1431.
84. Songisepp E., Kals J., Kullisaar T., Mandar R., Hutt P., Zilmer M., Mikelsaar M. Evaluation of the functional efficacy of an antioxidative probiotic in healthy volunteers. Nutrition Journal 2005, 4:22.
85. Stone W.L., Krishnan K., Campbell S.E., Palau V.E. The role of antioxidants and pro-oxidants in colon cancer. World Journal of Gastrointestinal Oncology 2014, 6(3):55-66.
86. Tang Y., Chen Y., Jiang H., Nie D. The role of short-chain fatty acids in orchestrating two types of programmed cell death in colon cancer. Autophagy 2011, 7(2):235-237.
87. Thirabunyanon M., Boonprasom P., Niamsup P. Probiotic potential of lactic acid bacteria isolated from fermented dairy milks on antiproliferation of colon cancer cells. Biotechnology Letters 2009, 31(4):571-576.
88. Thirabunyanon M., Hongwittayakorn P. Potential probiotic lactic acid bacteria of human origin induce antiproliferation of colon cancer cells via synergic actions in adhesion to cancer cells and short-chain fatty acid bioproduction. Applied Biochemistry and Biotechnology 2013, 169(2):511-525.
89. Turner N.D., Ritchie L.E., Bresalier R.S., Chapkin R.S. The microbiome and colorectal neoplasia: Environmental modifiers of dysbiosis. Current Gastroenterology Reports 2013, 15(9):346.
90. Uccello M., Malaguarnera G., Basile F., D'Agata V., Malaguarnera M., Bertino G., Biondi A. Potential role of probiotics on colorectal cancer prevention. BMC Surgery 2012, 12(Suppl. 1):S35.
91. Ulluwishewa D., Anderson R.C., McNabb W.C., Moughan P.J., Wells J.M., Roy N.C. Regulation of tight junction permeability by intestinal bacteria and dietary components. The Journal of Nutrition 2011, 141(5):769-776.
92. Verma A., Shukla G. Synbiotic (Lactobacillus rhamnosus+Lactobacillus acidophilus+inulin) attenuates oxidative stress and colonic damage in 1,2 dimethylhydrazine dihydrochloride-induced colon carcinogenesis in Sprague-Dawley rats: A long-term study. European Journal of Cancer Prevention 2014, 23(6):550-559.
93. Wan Y., Xin Y., Zhang C., Wu D., Ding D., Tang L., Li W. Fermentation supernatants of inhibit growth of human colon cancer cells and induce apoptosis through a caspase 3-dependent pathway. Oncology letter 2014, 7(5):1738-1742.
94. Wang L., Zhang J., Guo Z., Kwok L., Ma C., Zhang W., Zhang H. Effect of oral consumption of probiotic Lactobacillus planatarum P-8 on fecal microbiota, SIgA, SCFAs, and TBAs of adults of different ages. Nutrition (Burbank, Los Angeles County, Calif.) 2014, 30(7-8):776-783e1.
95. Wu N., Yang X., Zhang R., Li J., Xiao X., Hu Y., Zhu B. Dysbiosis signature of fecal microbiota in colorectal cancer patients. Microbial Ecology 2013, 66(2):462-470.
96. Zeng H., Lazarova D.L., Bordonaro M. Mechanisms linking dietary fiber, gut microbiota and colon cancer prevention. World J Gastrointest Oncol 2014, 6(2):41-51.
97. Zhang H., Sun J., Liu X., Hong C., Zhu Y., Liu A., Ren F. Lactobacillus paracasei subsp. paracasei LC01 positively modulates intestinal microflora in healthy young adults. Journal of Microbiology (Seoul, Korea) 2013, 51(6):777-782.
98. Zhong L., Zhang X., Covasa M. Emerging roles of lactic acid bacteria in protection against colorectal cancer. World Journal of Gastroenterology 2014, 20(24):7878-7886.
99. Zhu Q., Gao R., Wu W., Qin H. The role of gut microbiota in the pathogenesis of colorectal cancer. Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine 2013, 34(3):1285-1300.